ACTIVE SUBSTANCE / INN

LUTETIUM (177LU) CHLORIDE

Brand name(s): EndolucinBeta, Theralugand, Lutetium (177Lu) chloride Billev (previously Illuzyce), Lumark, Ilumira
EMA LISTED
WITHDRAWN
AUTHORISED
OPINION
Radionuclide Imaging
ACTIVE SUBSTANCE
Lutetium (177Lu) Chloride
REGULATORS
EMA
SPONSORS / MAH
Billev Pharma Aps, Shine Europe B.V., ITM Medical Isotopes GmbH
TOTAL APPLICATIONS
5
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LumarkI.D.B. Radiopharmacy B.V.Withdrawn18/06/2015Radionuclide Imaging
IlumiraShine Europe B.V.OpinionRadionuclide Imaging
EndolucinBetaITM Medical Isotopes GmbHAuthorised06/07/2016Radionuclide Imaging
TheralugandEckert & Ziegler Radiopharma GmbHAuthorised22/11/2024Radionuclide Imaging
Lutetium (177Lu) chloride Billev (previously Illuzyce)Billev Pharma ApsAuthorised15/09/2022Radionuclide Imaging

FULL INTELLIGENCE ON LUTETIUM (177LU) CHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →